Oncology Market Research Reports, Analysis & Trends

Publication Single User License (PDF) Price
Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023

Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023

Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
PharmaPoint: Colorectal Cancer - Current and Future Players

PharmaPoint: Colorectal Cancer - Current and Future Players

Date Published: Nov 28 2014
$2,995.00
Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023

Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$4,995.00
Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$6,995.00
Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023

Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$4,995.00
MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023

MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$4,995.00
Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023

Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023

Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023

Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023

Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023

Date Published: Nov 28 2014
$3,495.00
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies

Date Published: Oct 31 2014
In Asia-Pacific Colorectal Cancer Therapeutics Market is expected to reach $2.9 Billion by 2020.
$4,995.00
Oncology Pharmaceuticals Market in India 2014

Oncology Pharmaceuticals Market in India 2014

Date Published: Sep 10 2014
$950.00
Skin Cancer Treatment Drugs Markets in China

Skin Cancer Treatment Drugs Markets in China

Date Published: Jun 1 2014

China's demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.

$4,000.00
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

Date Published: Jun 1 2014
$4,995.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data